| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f664356294234e6c9aed711394a36e40 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K51-121
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G21G4-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K51-0497
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K51-088
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K51-1096 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K51-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C22B3-42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G21G1-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/B01J20-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/B01J20-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C22B60-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/B01J39-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G21G4-08 |
| filingDate |
2022-01-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_eeb5caf574a1901c732a89231167ba46
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_02d8f3787838af625934797fe5945cfb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0dc4c9e613c668322348727427c27cb8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a2adde84cf43ef419fe042f2b855c835
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c302190728add6117cce6f54c15b67d3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_52e9391793662f679ca9e5eff3da6955
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c4bc80a9b5b8de38467d06df7edfe25b |
| publicationDate |
2022-09-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
TW-202235093-A |
| titleOfInvention |
Manufacturing method of Ac-225 solution and manufacturing method of medicine using Ac-225 solution |
| abstract |
One aspect of the present invention is directed to providing a method for producing a solution of 225 Ac with suppressed decay of 225 Ac and a higher concentration of 225 Ac. One aspect of the present invention relates to a method for producing a 225 Ac solution or a method for producing a medicine using the solution. The method for producing the 225 Ac solution includes: irradiating particles to a 226 Ra target to generate two or more species containing at least 225 Ac. The step of the radioactive isotope (Ac) of actinium; the step of dissolving the 226 Ra target after the step to obtain a solution (1) containing 226 Ra and Ac; separating the 226 Ra and Ac contained in the solution (1) to obtain The step of the solution (2) having an increased Ac concentration compared with the solution (1); decaying Ac other than 225 Ac contained in the solution (2) to obtain a solution containing the isotope (Ra) of radium obtained by the decay The step of (3); and the step of separating the Ra and Ac contained in the solution (3) to obtain a solution (4) whose concentration of 225 Ac is increased compared with that of the solution (3); and the solution (4) is used to manufacture medicine , the medicine contains a complex of a chelating agent complexed with 225 Ac and an Nd2 antibody or a targeting agent (excluding Nd2 antibody) as an active ingredient. |
| priorityDate |
2021-01-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |